The U.S. Food and Drug Administration has approved the first-in-class TRPM8 receptor agonist Tryptyr (acoltremon ophthalmic ...

For open-angle glaucoma or ocular hypertension well controlled by eye drops, secondary selective laser trabeculoplasty ...

Researchers share that perfluorohexylactane eye drops offer rapid relief for dry eye disease, enhancing patient comfort ...

Tryptyr, a new dry eye treatment, is approved. Learn why Black participation in clinical trials is vital for effective, ...

Learn which drugs can cause dry eye disease, and what to do if you’re taking a medication that can cause dry eye symptoms.

Whether they’re suffering from red, itchy eyes during allergy season, dealing with the discomfort of ear wax buildup or ...

The FDA cleared an investigational new drug application for a phase 2 trial of GRF312 ophthalmic solution, an immunoglobulin eye drop for the treatment of dry eye disease, according to a press release ...

Six years after being spun out from Novartis and becoming a public company, eye care specialist Alcon has gained its first ...

Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic community.

The FDA has approved Tryptyr (acoltremon) as the first TRPM8-targeting eye drop for dry eye disease, stimulating natural tear production as early as day one.

A new randomized controlled trial reveals that topical timolol significantly improves the appearance of post-mammoplasty ...